Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 9, 2021
A Phase 1 Study Evaluating Rovalpituzumab Tesirine in Frontline Treatment of Patients With Extensive-Stage SCLCChristine L Hann, Timothy F Burns, Afshin Dowlati, et al.
Molecular Oncology|November 25, 2022
Early circulating tumor DNA dynamics as a pan-tumor biomarker for long-term clinical outcome in patients treated with durvalumab and tremelimumabMaya Kansara, Neeru Bhardwaj, Subotheni Thavaneswaran, et al.
JAMA Network Open|November 4, 2024
Actionable Structural Variant Detection via RNA-NGS and DNA-NGS in Patients With Advanced Non-Small Cell Lung CancerDwight Owen, Rotem Ben-Shachar, Josephine Feliciano, et al.
European Journal of Cancer (Oxford, England : 1990)|June 20, 2013
Radioembolisation for liver metastases: results from a prospective 151 patient multi-institutional phase II studyAl B Benson, Jean-Francois Geschwind, Mary F Mulcahy, et al.
International Journal of Molecular Sciences|October 14, 2022
Comprehensive Genomic Profiling (CGP)-Informed Personalized Molecular Residual Disease (MRD) Detection: An Exploratory Analysis from the PREDATOR Study of Metastatic Colorectal Cancer (mCRC) Patients Undergoing Surgical ResectionSara Lonardi, Halla Nimeiri, Chang Xu, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 8, 2014
Twelve-year experience of radioembolization for colorectal hepatic metastases in 214 patients: survival by era and chemotherapyRobert J Lewandowski, Khairuddin Memon, Mary F Mulcahy, et al.
JCO Precision Oncology|September 4, 2025
Real-World Validation of the Purity Independent Subtyping of Tumors Classifier for Informing Therapy Selection in Pancreatic Ductal AdenocarcinomaStephane Wenric, Chithra Sangli, John Guittar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2022
Neoadjuvant Chemotherapy, Excision, and Observation for Early Rectal Cancer: The Phase II NEO Trial (CCTG CO.28) Primary End Point ResultsHagen F Kennecke, Chris J O'Callaghan, Jonathan M Loree, et al.
Frontiers in Oncology|August 21, 2023
Molecular residual disease detection in resected, muscle-invasive urothelial cancer with a tissue-based comprehensive genomic profiling-informed personalized monitoring assayThomas Powles, Amanda Young, Halla Nimeiri, et al.
Oncology and Therapy|July 22, 2024
Dynamic Changes in Circulating Tumor Fraction as a Predictor of Real-World Clinical Outcomes in Solid Tumor Malignancy Patients Treated with ImmunotherapyRyan D Gentzler, John Guittar, Akash Mitra, et al.
Pageof 4